Literature DB >> 3554910

Motor neuron disease: epidemiologic studies.

D W Mulder, L T Kurland.   

Abstract

The etiology of motor neuron disease (MND) is unknown and treatment is limited to measures which sustain the patient. We review selected epidemiologic studies searching for a pattern in the clinical expression of MND which may reflect the operation of the underlying cause. Recognition of patterns of occurrence of MND might provide the basis for testable etiologic hypotheses for MND. In addition, recognition of the association of MND with diseases of known cause or the analogy of diseases of known cause with MND may provide further etiologic hypotheses.

Entities:  

Mesh:

Year:  1987        PMID: 3554910     DOI: 10.1007/978-1-4684-5302-7_49

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

Review 1.  MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.

Authors:  Frank Cloutier; Alier Marrero; Colleen O'Connell; Pier Morin
Journal:  J Mol Neurosci       Date:  2014-11-30       Impact factor: 3.444

2.  Motor neurone disease: a hospice perspective.

Authors:  T O'Brien; M Kelly; C Saunders
Journal:  BMJ       Date:  1992-02-22

Review 3.  The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.

Authors:  Sandra Anne Banack; Tracie A Caller; Elijah W Stommel
Journal:  Toxins (Basel)       Date:  2010-12-20       Impact factor: 4.546

4.  Mapping amyotrophic lateral sclerosis lake risk factors across northern New England.

Authors:  Nathan Torbick; Sarah Hession; Elijah Stommel; Tracie Caller
Journal:  Int J Health Geogr       Date:  2014-01-02       Impact factor: 3.918

5.  Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme.

Authors:  Aurélie Delzor; Philippe Couratier; Farid Boumédiène; Marie Nicol; Michel Druet-Cabanac; François Paraf; Annick Méjean; Olivier Ploux; Jean-Philippe Leleu; Luc Brient; Marion Lengronne; Valérie Pichon; Audrey Combès; Saïda El Abdellaoui; Vincent Bonneterre; Emmeline Lagrange; Gérard Besson; Dominique J Bicout; Jean Boutonnat; William Camu; Nicolas Pageot; Raul Juntas-Morales; Valérie Rigau; Estelle Masseret; Eric Abadie; Pierre-Marie Preux; Benoît Marin
Journal:  BMJ Open       Date:  2014-09-01       Impact factor: 2.692

6.  Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis.

Authors:  Nathan Torbick; Beth Ziniti; Elijah Stommel; Ernst Linder; Angeline Andrew; Tracie Caller; Jim Haney; Walter Bradley; Patricia L Henegan; Xun Shi
Journal:  Neurotox Res       Date:  2017-10-03       Impact factor: 3.911

7.  Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020-2116.

Authors:  Alison Gowland; Sarah Opie-Martin; Kirsten M Scott; Ashley R Jones; Puja R Mehta; Christine J Batts; Cathy M Ellis; P Nigel Leigh; Christopher E Shaw; Jemeen Sreedharan; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-04-09       Impact factor: 4.092

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.